209 related articles for article (PubMed ID: 30100157)
1. Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size.
Tsimikas S; Fazio S; Viney NJ; Xia S; Witztum JL; Marcovina SM
J Clin Lipidol; 2018; 12(5):1313-1323. PubMed ID: 30100157
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
Chan DC; Watts GF; Coll B; Wasserman SM; Marcovina SM; Barrett PHR
J Am Heart Assoc; 2019 Apr; 8(7):e011781. PubMed ID: 30897995
[TBL] [Abstract][Full Text] [Related]
3. Different apoprotein(a) isoform proportions in serum and carotid plaque.
Baldo G; Giunco S; Kontothanassis D; Baiocchi MR; Valerio A; Frego M
Atherosclerosis; 2007 Jul; 193(1):177-85. PubMed ID: 16839560
[TBL] [Abstract][Full Text] [Related]
4. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
Rifai N; Ma J; Sacks FM; Ridker PM; Hernandez WJ; Stampfer MJ; Marcovina SM
Clin Chem; 2004 Aug; 50(8):1364-71. PubMed ID: 15155542
[TBL] [Abstract][Full Text] [Related]
6. Study of apo(a) length polymorphism and lipoprotein(a) concentrations in subjects with single or double apo(a) isoforms.
Alaoui M; Merle C; Garnotel R; Jolly D; Durlach V; Gillery P
Clin Chem Lab Med; 2003 May; 41(5):634-9. PubMed ID: 12812260
[TBL] [Abstract][Full Text] [Related]
7. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
Hopewell JC; Seedorf U; Farrall M; Parish S; Kyriakou T; Goel A; Hamsten A; Collins R; Watkins H; Clarke R;
J Intern Med; 2014 Sep; 276(3):260-8. PubMed ID: 24372611
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms.
Contois JH; Nguyen RA; Albert AL
Clin Chim Acta; 2020 Jun; 505():119-124. PubMed ID: 32113814
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
[TBL] [Abstract][Full Text] [Related]
10. The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.
Blanchard V; Chemello K; Hollstein T; Hong-Fong CC; Schumann F; Grenkowitz T; Nativel B; Coassin S; Croyal M; Kassner U; Lamina C; Steinhagen-Thiessen E; Lambert G
Cardiovasc Res; 2022 Jul; 118(9):2103-2111. PubMed ID: 34314498
[TBL] [Abstract][Full Text] [Related]
11. Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort.
Matveyenko A; Matienzo N; Ginsberg H; Nandakumar R; Seid H; Ramakrishnan R; Holleran S; Thomas T; Reyes-Soffer G
J Lipid Res; 2023 Mar; 64(3):100336. PubMed ID: 36706955
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
Viney NJ; van Capelleveen JC; Geary RS; Xia S; Tami JA; Yu RZ; Marcovina SM; Hughes SG; Graham MJ; Crooke RM; Crooke ST; Witztum JL; Stroes ES; Tsimikas S
Lancet; 2016 Nov; 388(10057):2239-2253. PubMed ID: 27665230
[TBL] [Abstract][Full Text] [Related]
13. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen.
Karwatowska-Prokopczuk E; Clouet-Foraison N; Xia S; Viney NJ; Witztum JL; Marcovina SM; Tsimikas S
Atherosclerosis; 2021 May; 324():102-108. PubMed ID: 33872986
[TBL] [Abstract][Full Text] [Related]
15. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
[TBL] [Abstract][Full Text] [Related]
16. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) mass: a massively misunderstood metric.
McConnell JP; Guadagno PA; Dayspring TD; Hoefner DM; Thiselton DL; Warnick GR; Harris WS
J Clin Lipidol; 2014; 8(6):550-553. PubMed ID: 25499936
[TBL] [Abstract][Full Text] [Related]
18. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
[TBL] [Abstract][Full Text] [Related]
19. Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer.
Wyness SP; Genzen JR
Pract Lab Med; 2021 May; 25():e00218. PubMed ID: 33898688
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with lipoprotein(a) in chronic kidney disease.
Uhlig K; Wang SR; Beck GJ; Kusek JW; Marcovina SM; Greene T; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Jan; 45(1):28-38. PubMed ID: 15696441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
